ciprofloxacin has been researched along with Actinomycetoma in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We developed an in vitro susceptibility assay for Actinomadura madurae, one of the common causative agents of actinomycetoma, employing resazurin for endpoint reading." | 8.12 | Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma. ( Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A, 2022) |
| "Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis." | 6.79 | The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection. ( Fahal, AH; Mahgoub, el S; Mhmoud, NA; van de Sande, WW, 2014) |
| "We developed an in vitro susceptibility assay for Actinomadura madurae, one of the common causative agents of actinomycetoma, employing resazurin for endpoint reading." | 4.12 | Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma. ( Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A, 2022) |
| "Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis." | 2.79 | The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection. ( Fahal, AH; Mahgoub, el S; Mhmoud, NA; van de Sande, WW, 2014) |
| "We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin." | 1.40 | Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin. ( Endy, TP; Nat, A; Rane, M; Sharma, AM; Sharma, N, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chacon-Moreno, BE | 1 |
| Welsh, O | 1 |
| Cavazos-Rocha, N | 1 |
| de la Luz Salazar-Cavazos, M | 1 |
| Garza-Lozano, HG | 1 |
| Said-Fernandez, S | 1 |
| Ocampo-Candiani, J | 1 |
| Vera-Cabrera, L | 1 |
| Abd Algaffar, SO | 1 |
| Verbon, A | 1 |
| Khalid, SA | 1 |
| van de Sande, WWJ | 1 |
| Soto Silva, A | 1 |
| Porte Torre, L | 1 |
| Dabanch Peña, J | 1 |
| Braun Jones, S | 1 |
| Mhmoud, NA | 1 |
| Fahal, AH | 1 |
| Mahgoub, el S | 1 |
| van de Sande, WW | 1 |
| Sharma, AM | 1 |
| Sharma, N | 1 |
| Nat, A | 1 |
| Rane, M | 1 |
| Endy, TP | 1 |
| Negroni, R | 2 |
| Bianchi, MH | 2 |
| Arechavala, AI | 2 |
| Maiolo, E | 2 |
| Santiso, G | 2 |
| Olivares, L | 1 |
| González, G | 1 |
| Orduna, T | 1 |
1 trial available for ciprofloxacin and Actinomycetoma
| Article | Year |
|---|---|
The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antif | 2014 |
6 other studies available for ciprofloxacin and Actinomycetoma
| Article | Year |
|---|---|
Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
Topics: Animals; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Female; Fluoroquinolones; Mice; Mice, | 2009 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosf | 2022 |
[Long-standing skin lesion in an immunocompetent male patient].
Topics: Actinomycetales; Actinomycetales Infections; Actinomycosis; Anti-Bacterial Agents; Ciprofloxacin; Cu | 2013 |
Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Therapy, | 2014 |
[Clinical cases in Medical Mycology. Case No. 28].
Topics: Abdominal Injuries; Agricultural Workers' Diseases; Anti-Bacterial Agents; Argentina; Ciprofloxacin; | 2007 |
[Clinical cases in Medical Mycology. Case No. 29].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Infectious; Bacteremia; Ciprofloxacin; C | 2007 |